Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial
- Resource Type
- Article
- Source
- In
Respiratory Investigation November 2022 60(6):787-797 - Subject
- Language
- ISSN
- 2212-5345